Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 11/20 | 0.77 |
| ▸ | KMT2A | Q03164 | 11/20 | 0.77 |
| ▸ | BLM | P54132 | 8/20 | 0.77 |
| ▸ | POLB | P06746 | 8/20 | 0.77 |
| ▸ | USP2 | O75604 | 4/20 | 0.77 |
| ▸ | GAA | P10253 | 4/20 | 0.77 |
| ▸ | DNMT1 | P26358 | 2/20 | 0.77 |
| ▸ | NSD2 | O96028 | 1/20 | 0.71 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.71 |
| ▸ | PPP1CA | P62136 | 1/20 | 0.69 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.69 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.69 |
| ▸ | ALPL | P05186 | 1/20 | 0.65 |
| ▸ | ALPI | P09923 | 1/20 | 0.65 |
| ▸ | ALPG | P10696 | 1/20 | 0.65 |
| ▸ | GRK2 | P25098 | 1/20 | 0.65 |
| ▸ | GALK1 | P51570 | 1/20 | 0.61 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.61 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.60 |
| ▸ | ITGB7 | P26010 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14777540 | 1.00 | MEN1 (0.77) | MEN1KMT2ABLMPOLBUSP2 | |
| SCHEMBL2493268 | 0.88 | MEN1 (0.80) | MEN1KMT2ABLMPOLBUSP2 | |
| SCHEMBL2493271 | 0.88 | MEN1 (0.80) | MEN1KMT2ABLMPOLBUSP2 | |
| SCHEMBL29504051 | 0.88 | MEN1 (0.75) | MEN1KMT2ABLMPOLBUSP2 | |
| SCHEMBL30457953 | 0.88 | MEN1 (0.78) | MEN1KMT2ABLMPOLBUSP2 | |
| SCHEMBL29504050 | 0.88 | MEN1 (0.75) | MEN1KMT2ABLMPOLBUSP2 | |
| SCHEMBL22396433 | 0.88 | MEN1 (0.75) | MEN1KMT2ABLMPOLBUSP2 | |
| SCHEMBL25633644 | 0.88 | MEN1 (0.78) | MEN1KMT2ABLMPOLBUSP2 | |
| SCHEMBL14444644 | 0.87 | MEN1 (1.00) | MEN1KMT2ABLMPOLBUSP2 | |
| SCHEMBL30457527 | 0.87 | MEN1 (1.00) | MEN1KMT2ABLMPOLBUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10098887-B2 | Antiviral compounds and methods of use thereof | TRANA DISCOVERY, INC. (US) | 2018-10-16 | — | — | US | disclosed |
| US-20160129006-A1 | ANTIVIRAL COMPOUNDS AND METHODS OF USE THEREOF | TRANA DISCOVERY INC (US) | 2016-05-12 | — | — | US | disclosed |
| US-9173886-B2 | Antiviral compounds and methods of use thereof | TRANA DISCOVERY, INC. (US) | 2015-11-03 | — | — | US | disclosed |
| US-20130071353-A1 | Antiviral Compounds and Methods of Use Thereof | TRANA DISCOVERY, INC (US) | 2013-03-21 | — | — | US | disclosed |
| WO-2011113060-A2 | ANTIVIRAL COMPOUNDS AND METHODS OF USE THEREOF | TRANA DISCOVERY, INC. (US) | 2011-09-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10098887-B2 | Antiviral compounds and methods of use thereof | TYMP, MAVS, ZC3HAV1 | MEN1 4495/4885KMT2A 2800/4885BLM 1967/4885 |
| US-20160129006-A1 | ANTIVIRAL COMPOUNDS AND METHODS OF USE THEREOF | TYMP, MAVS, ZC3HAV1 | MEN1 4495/4885KMT2A 2800/4885BLM 1967/4885 |
| US-20130071353-A1 | Antiviral Compounds and Methods of Use Thereof | TYMP, MAVS, ZC3HAV1 | MEN1 4495/4885KMT2A 2800/4885BLM 1967/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.